1. COPANLISIB AND VOLASERTIB OVERCOME IBRUTINIB‐VENETOCLAX RESISTANCE VIA TARGETING PI3K‐AKT SIGNALING AND G2/M CELL CYCLE TRANSITION IN MANTLE CELL LYMPHOMA. (12th June 2019) Authors: Zhang, R.; Lee, W.; Huang, S.; Liu, Y.; Leeming, A.H.; McIntosh, J.M.; Nomie, K.J.; Jiang, C.V.; Wang, M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗